After a year with KTH Innovation pre-incubators program, we have secured our first investment by KTH Holding AB! The entire team at Ovulai is thrilled and honored to be receiving this investment as it’ll allow us to accelerate our product and app development to launch the first digital therapeutics to alleviate menstrual disorders, starting with PCOS!
Read more about our plans in this article!